You guys don't see this whole thing as part of mistake that showed lower than expected numbers and a demand for an explanation, that was probably unsatisfactory, causing a renegotiation, the ngio shares were added to make the deal more palatable. I believe that you guys were corr3with your original assumptions, but Veneto pulled some interpretive accounting. Joe and team had choice go to court or renegotiate, this is a result of that renegotiation. Terms were changed, but not fully explained to shareholders. I preface these comments with the fact I am a cynical bastard, and I feel that Joe is juggling and people keep adding balls for him to maintain.
he (Joe) sounds very cool on the CC but on the board things are a little more fluid and emotional. He tends to react from the gut. Most of us have watched the slow drip drip drip of old Generex, Joe's right, it wasn't his watch, he is trying to save it but for us shareholders, still living with the pain of the past are sensitive to the future. Read the posts over the last several months, we are all still buying on the dips. Nothing wrong with trying to get as much clarity as possible.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links